Gates Foundation Plots A Fresh Metric For Market Access: Lives Saved
Gates Medical Research Institute’s Access To Affordability Model Combines Private Sector Know-How With The Public Good
In Vivo visits Gates Medical Research Institute CEO Dr. Penny Heaton to review its first pipeline of drugs and vaccines to attack four of the world’s biggest killers: TB, malaria, enteric diseases and other conditions affecting maternal, newborn and child health.
You may also be interested in...
In case you missed it: catch up with snippets from interviews recently published by In Vivo.
Insights from Gates Medical Research Institute CEO Dr. Penny Heaton.
Big pharma is facing a difficult US competitive landscape as its traditional customers realign to build their own redoubts of size, scale and reach.